JP2024026109A5 - - Google Patents
Info
- Publication number
- JP2024026109A5 JP2024026109A5 JP2023195583A JP2023195583A JP2024026109A5 JP 2024026109 A5 JP2024026109 A5 JP 2024026109A5 JP 2023195583 A JP2023195583 A JP 2023195583A JP 2023195583 A JP2023195583 A JP 2023195583A JP 2024026109 A5 JP2024026109 A5 JP 2024026109A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- peptide
- seq
- nos
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762598067P | 2017-12-13 | 2017-12-13 | |
| US62/598,067 | 2017-12-13 | ||
| PCT/US2018/065545 WO2019118779A2 (en) | 2017-12-13 | 2018-12-13 | Peptides and other agents for treating pain and increasing pain sensitivity |
| JP2020532629A JP2021506794A (ja) | 2017-12-13 | 2018-12-13 | 疼痛を治療し、疼痛感受性を増大させるためのペプチド及び他の薬剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532629A Division JP2021506794A (ja) | 2017-12-13 | 2018-12-13 | 疼痛を治療し、疼痛感受性を増大させるためのペプチド及び他の薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024026109A JP2024026109A (ja) | 2024-02-28 |
| JP2024026109A5 true JP2024026109A5 (enExample) | 2026-04-14 |
Family
ID=66820711
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532629A Pending JP2021506794A (ja) | 2017-12-13 | 2018-12-13 | 疼痛を治療し、疼痛感受性を増大させるためのペプチド及び他の薬剤 |
| JP2023195583A Pending JP2024026109A (ja) | 2017-12-13 | 2023-11-17 | 疼痛を治療し、疼痛感受性を増大させるためのペプチド及び他の薬剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532629A Pending JP2021506794A (ja) | 2017-12-13 | 2018-12-13 | 疼痛を治療し、疼痛感受性を増大させるためのペプチド及び他の薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11535649B2 (enExample) |
| EP (1) | EP3723781B1 (enExample) |
| JP (2) | JP2021506794A (enExample) |
| CN (1) | CN111712252A (enExample) |
| AU (1) | AU2018383669B2 (enExample) |
| CA (1) | CA3085576A1 (enExample) |
| IL (1) | IL275340A (enExample) |
| WO (1) | WO2019118779A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111712252A (zh) * | 2017-12-13 | 2020-09-25 | 纽约州立大学研究基金会 | 用于治疗疼痛和提高疼痛敏感性的肽和其它药剂 |
| WO2021072392A1 (en) * | 2019-10-10 | 2021-04-15 | The Research Foundation For The State University Of New York | Analgesic and anesthetic peptides and other agents |
| WO2022193185A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New conjugates |
| WO2025102083A1 (en) * | 2023-11-12 | 2025-05-15 | The Research Foundation For The State University Of New York | Compositions and methods for treating pain or for increasing pain sensitivity |
| WO2025123001A1 (en) * | 2023-12-08 | 2025-06-12 | Washington University | Targeted protein degradation compositions and methods of use thereof for pain control |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6187533B1 (en) * | 1996-09-10 | 2001-02-13 | Arch Development Corporation | Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (α), HNF1β and HNF4α |
| HUP0200575A3 (en) * | 1999-03-25 | 2004-11-29 | Abbott Gmbh & Co Kg | Human antibodies that bind human il-12 and methods for producing |
| DE1252330T1 (de) | 1999-11-26 | 2003-11-27 | Mcgill University, Montreal | Loci der idiopathischen epilepsie, mutationen derselben und verfahren zu deren verwendung zur feststellung, prognose und behandlung von epilepsie |
| US20030216310A1 (en) | 2001-05-25 | 2003-11-20 | Thornton Michael B. | Transporters and ion channels |
| US20090087436A1 (en) | 2001-07-13 | 2009-04-02 | Myriad Genetics, Incorporated | Compositions and methods for treating diseases |
| WO2004045535A2 (en) | 2002-11-14 | 2004-06-03 | Arbor Vita Corporation | Molecular interactions in neurons |
| CA2462732A1 (en) * | 2001-10-01 | 2003-04-10 | Buck Institute | Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires |
| US20040101874A1 (en) | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
| US20040180848A1 (en) | 2003-03-10 | 2004-09-16 | Fesik Stephen W. | Method of killing cancer cells |
| BRPI0417531A (pt) | 2003-12-12 | 2007-03-20 | Wyeth Corp | canal de sódio |
| EP1709084A4 (en) | 2003-12-23 | 2008-05-28 | Nono Inc | POLYPEPTIDES FOR MODULATING BINDING OF TRP-CHANNEL PROTEINS AND TRP-ASSOCIATED PROTEINS |
| WO2005118614A1 (en) * | 2004-04-08 | 2005-12-15 | Avigen, Inc. | Methods and compositions for treating neuropathic pain |
| US7485468B2 (en) | 2004-10-15 | 2009-02-03 | Galapagos Bv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| EP1904630A4 (en) | 2005-06-16 | 2009-10-21 | Bionomics Ltd | METHODS OF TREATING AND DIAGNOSING EPILEPSY BY DETECTING MUTATIONS OF THE SCN1A GENE |
| AU2008261951A1 (en) | 2007-06-08 | 2008-12-18 | Asuragen, Inc. | miR-34 regulated genes and pathways as targets for therapeutic intervention |
| WO2009006555A2 (en) | 2007-07-02 | 2009-01-08 | Yu, Ming | Methods, composition, targets for combinational cancer treatments |
| US20090118301A1 (en) | 2007-11-02 | 2009-05-07 | Arbor Vita Corporation | Compositions and Methods for Treating Cancer |
| CN102088990A (zh) | 2008-05-16 | 2011-06-08 | 阿尔伯维塔公司 | 癫痫的治疗 |
| EP2334379A2 (en) | 2008-09-26 | 2011-06-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Host cell kinases as targets for antiviral therapies against hcv infection |
| EP2275545A1 (en) | 2009-07-16 | 2011-01-19 | Julius-Maximilians-Universität Würzburg | Use of microRNA-24 and/or its targets for the treatment and prevention of ischemia and induction of angiogenesis |
| US8575112B2 (en) * | 2009-09-18 | 2013-11-05 | University Of Houston System | Small peptide modulators of potassium channel trafficking |
| US9279003B2 (en) * | 2010-07-07 | 2016-03-08 | Purdue Pharma L.P. | Analogs of sodium channel peptide toxin |
| JP5998131B2 (ja) | 2010-07-14 | 2016-09-28 | カッパーアールエヌエー，インコーポレイテッド | Ｄｉｓｃｓｌａｒｇｅｈｏｍｏｌｏｇ（ｄｌｇ）ｄｌｇ１への天然アンチセンス転写物の阻害によるｄｌｇ関連疾患の治療 |
| ES2655112T3 (es) | 2010-08-12 | 2018-02-16 | Nono Inc. | Tratamiento de una lesión penetrante en el cerebro |
| US9765115B2 (en) | 2011-04-01 | 2017-09-19 | Board of Supervisors of Louisiana State University acting on behalf of the University of Louisiana at Monroe | Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications |
| EP2773366B1 (en) * | 2011-11-04 | 2017-03-01 | Lipotec, S.A. | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| EP3419621A4 (en) * | 2016-02-26 | 2019-10-30 | The Johns Hopkins University | PHARMACOLOGICAL MODULATORS OF NAV1.1 VOLTAGE-CONTROLLED SODIUM CHANNELS ASSOCIATED WITH MECHANICAL PAIN |
| CN111712252A (zh) * | 2017-12-13 | 2020-09-25 | 纽约州立大学研究基金会 | 用于治疗疼痛和提高疼痛敏感性的肽和其它药剂 |
-
2018
- 2018-12-13 CN CN201880089341.7A patent/CN111712252A/zh active Pending
- 2018-12-13 AU AU2018383669A patent/AU2018383669B2/en active Active
- 2018-12-13 WO PCT/US2018/065545 patent/WO2019118779A2/en not_active Ceased
- 2018-12-13 JP JP2020532629A patent/JP2021506794A/ja active Pending
- 2018-12-13 EP EP18887737.7A patent/EP3723781B1/en active Active
- 2018-12-13 US US16/771,204 patent/US11535649B2/en active Active
- 2018-12-13 CA CA3085576A patent/CA3085576A1/en active Pending
-
2020
- 2020-06-14 IL IL275340A patent/IL275340A/en unknown
-
2022
- 2022-09-29 US US17/956,031 patent/US12077610B2/en active Active
-
2023
- 2023-11-17 JP JP2023195583A patent/JP2024026109A/ja active Pending
-
2024
- 2024-08-28 US US18/818,129 patent/US20250154199A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024026109A5 (enExample) | ||
| Mehta et al. | Beyond receptors and signaling: epigenetic factors in the regulation of innate immunity | |
| JP2021506794A5 (enExample) | ||
| JP2020023567A5 (enExample) | ||
| US20050037992A1 (en) | Composition and method for treating neurological disorders | |
| RU2009118960A (ru) | Комбинации ацетаминофена/ибуппрофена | |
| CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
| EA022459B1 (ru) | Производные транилципромина в качестве ингибиторов гистон деметилаз lsd1 и/или lsd2 | |
| RU2007139915A (ru) | Haemophilus influenzae типа в | |
| RU2010140886A (ru) | Применение дефенсинов при туберкулезе | |
| RU2013126581A (ru) | Мутанты стрептокиназы и их ковалентно модифицированные формы | |
| EP2450048A3 (en) | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase | |
| JP2005504782A5 (enExample) | ||
| RU2013120135A (ru) | Глюкозозависимые инсулинотропные пептидные аналоги | |
| TW201629085A (zh) | 芋螺毒素（ｃｏｎｏｔｏｘｉｎ）肽之修飾及用途 | |
| JP2004531242A5 (enExample) | ||
| WO2015184279A1 (en) | Compositions and methods for treating kabuki syndrome and related disorders | |
| CO5670327A2 (es) | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion | |
| JP2004517057A5 (enExample) | ||
| CN1173897A (zh) | 真核起始因子5A(eIF－5A)突变体 | |
| US20170095436A1 (en) | Methods for treating mendelian disorders of the epigenetic machinery | |
| EP3955930B1 (en) | Methods for predicting neisseria spp. susceptibility to cefixime | |
| Pourhajibagher et al. | Evaluation of the crystal structure of a fimbrillin (FimA) from Porphyromonas gingivalis as a therapeutic target for photo-activated disinfection with toluidine blue O | |
| JP2022551467A5 (enExample) | ||
| RU2005131578A (ru) | Аплидин для лечения множественной миеломы |